Literature DB >> 15708001

Improved gene delivery into neuroglial cells using a fiber-modified adenovirus vector.

Insil Joung1, Greg Harber, Kimberly M Gerecke, Steven L Carroll, James F Collawn, Jeffrey A Engler.   

Abstract

One impediment to treating neuronal diseases is finding ways to introduce genes into specific neuroglial cell types. Here we describe the strategy for efficient gene delivery via transferrin receptor using an adenovirus bearing a peptide mimic for transferrin. The attachment of the peptide consisted of 12 amino acids on the C-terminus of adenovirus fiber protein significantly improved entry and expression of a beta-galactosidase transgene into neuroglial cells such as astrocytes, and Schwann cells. The entry of re-targeted viruses into cells depends on the attached peptide and the transferrin receptor. Furthermore, transferrin did not affect gene delivery by the engineered adenovirus, suggesting that the effectiveness of therapeutic agents targeted to the receptor would not be diminished by competition with the abundant endogenous transferrin present in the plasma. Therefore, such transduction systems hold promise for efficient delivering gene to neuroglial cells in gene therapy protocols.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708001     DOI: 10.1016/j.bbrc.2005.01.080

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Crossing the Iron Gate: Why and How Transferrin Receptors Mediate Viral Entry.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2018-05-31       Impact factor: 11.848

2.  Infectivity-selective oncolytic adenovirus developed by high-throughput screening of adenovirus-formatted library.

Authors:  Yoshiaki Miura; Satoshi Yamasaki; Julia Davydova; Eric Brown; Kazunori Aoki; Selwyn Vickers; Masato Yamamoto
Journal:  Mol Ther       Date:  2012-10-02       Impact factor: 11.454

3.  Development of a novel efficient method to construct an adenovirus library displaying random peptides on the fiber knob.

Authors:  Yuki Yamamoto; Naoko Goto; Kazuki Miura; Kenta Narumi; Shumpei Ohnami; Hiroaki Uchida; Yoshiaki Miura; Masato Yamamoto; Kazunori Aoki
Journal:  Mol Pharm       Date:  2014-01-24       Impact factor: 4.939

Review 4.  The Development of Oncolytic Adenovirus Therapy in the Past and Future - For the Case of Pancreatic Cancer

Authors:  Mizuho Sato-Dahlman; Masato Yamamoto
Journal:  Curr Cancer Drug Targets       Date:  2018       Impact factor: 3.428

5.  Development of peritoneal tumor-targeting vector by in vivo screening with a random peptide-displaying adenovirus library.

Authors:  Takeshi Nishimoto; Yuki Yamamoto; Kimiko Yoshida; Naoko Goto; Shumpei Ohnami; Kazunori Aoki
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

6.  Tropism-modification strategies for targeted gene delivery using adenoviral vectors.

Authors:  Lynda Coughlan; Raul Alba; Alan L Parker; Angela C Bradshaw; Iain A McNeish; Stuart A Nicklin; Andrew H Baker
Journal:  Viruses       Date:  2010-10-13       Impact factor: 5.818

Review 7.  Engineered biological entities for drug delivery and gene therapy protein nanoparticles.

Authors:  Joan Domingo-Espín; Ugutz Unzueta; Paolo Saccardo; Escarlata Rodríguez-Carmona; José Luís Corchero; Esther Vázquez; Neus Ferrer-Miralles
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

Review 8.  Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury.

Authors:  Anastasiia O Sosnovtseva; Olga V Stepanova; Aleksei A Stepanenko; Anastasia D Voronova; Andrey V Chadin; Marat P Valikhov; Vladimir P Chekhonin
Journal:  Front Pharmacol       Date:  2022-01-10       Impact factor: 5.810

Review 9.  Role of Gene Therapy in Pancreatic Cancer-A Review.

Authors:  Mizuho Sato-Dahlman; Keith Wirth; Masato Yamamoto
Journal:  Cancers (Basel)       Date:  2018-04-03       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.